for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Sanofi sees Soliqua costing about same as a GLP-1 drug in U.S.

Nov 22 (Reuters) - Sanofi :

* Says expects daily wholesale acquisition cost of new diabetes drug Soliqua will be similar to daily price of a GLP-1 in U.S.

* Comment made by spokesman in response to Reuters inquiry Further company coverage: (Reporting by UK bureau)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up